Many processes, including vesicle trafficking, are regulated by phosphoinositides (1, 2) . Binding of phosphoinositides to protein domains like pleckstrin homology (PH) domains and FYVE domains targets proteins to specific parts of the membrane. Proper signal transduction by phosphoinositides requires a tight control of their local concentrations. The formation of clathrin-coated vesicles and phagocytic cups is accompanied by the localized production of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P 3 ), respectively (3, 4) . One group of enzymes regulating the formation and degradation of phosphoinositides are inositol 5-phosphatases [reviewed by Erneux et al. (5) ]. These enzymes remove the phosphate group from the 5-position of the inositol ring. The mammalian inositol 5-phosphatase SHIP (SRC Homology 2 Domain-containing Inositol-5-Phosphatase) is recruited to the membrane of the phagocytic cup, and negatively regulates phagocytosis (6) . The inositol 5-phosphatase synaptojanin regulates vesicle recycling in the synapse (7) . A role in vesicle trafficking is also proposed for the inositol 5-phosphatase OCRL (oculocerebrorenal syndrome of Lowe) (8) . This protein contains a catalytic inositol 5-phosphatase domain and a C-terminal RhoGAP domain and localizes to trans Golgi network (TGN) in fibroblasts (8) , consistent with a role of OCRL in lysosomal enzyme trafficking from the TGN to lysosomes (9) . More recently, it has been demonstrated that OCRL protein associates with clathrin, localizes to endosomes and is proposed to play a role in clathrin-mediated trafficking of proteins from endosomes to the TGN (10, 11) . Mutations in the gene coding for OCRL results in the oculocerebrorenal syndrome of Lowe, affecting functions of the lens, kidney and nervous system (12) . At a molecular level, elevated levels of PI(4,5)P 2 are observed (13, 14) and the amount of long actin stress fibers in fibroblasts is decreased (15) .
As in mammalian cell lines, phosphoinositides are also involved in endocytosis in the social amoeba Dictyostelium discoideum [reviewed in (16) ]. Their natural food source, bacteria, are ingested via phagocytosis and the commonly used strain AX3 grows axenically by means of macropinocytosis. Inhibitors of the enzyme phospholipase C (PLC), which converts PI(4,5)P 2 into inositol 1,4,5-trisphosphate and diacylglycerol, drastically reduce the rate of phagocytosis (17) . However, inactivation of the gene encoding the single D. discoideum PI(4,5)P 2 -PLC does not affect growth (18) . This suggests that the cells can switch to a PLCindependent pathway. Inactivation of the PI(3,4,5)P 3 producing phosphatidylinositol 3-kinases (PI3Ks) DdPIK1 and DdPIK2 decreases the rate of pinocytosis; however, phagocytosis is only slightly inhibited (19) . On the other hand, both pinocytosis and growth on Klebsiella aerogens are inhibited by inactivation of the inositol 3-phosphatase PTEN (Phosphatase and Tensin-Homolog) (20) . Five inositol 5-phosphatases, Dd5P1-4 and PLIP (phospholipid-inositol phosphatase), have been identified in D. discoideum (21, 22) . Dd5P1-4 are inositol 5-phosphatases containing the conserved motifs I and II (WXGDXN(Y/F)R and P(A/S)W(C/T)DR(I/V)L) that are characteristic for inositol 5-phosphatases. The catalytic domain of Dd5P1 shows the highest similarity with SHIP, but lacks the N-terminal SH2 domain. A unique domain composition is present in Dd5P2 containing a 5-phosphatase and a RCC1-like domain. Dd5P3 and Dd5P4 have a domain composition similar to synaptojanin with a Sac1 domain, and to OCRL with a RhoGAP domain, respectively ( Figure 1A) . PLIP is not a classical inositol 5-phosphatase, as it does not contain the conserved motifs I and II. In stead, the amino acid sequence shows highest similarity with the inositol 3-phosphatase PTEN, although the preferred in vitro substrate is PI(5)P. Amino acids conserved between the RhoGAP domains of human RhoGAP, D. discoideum Dd5P4 and human OCRL are shown in black (100% identity) or gray (100% similarity). Asterisks indicate amino acids that interact with a small G protein as suggested by the crystal structure of RhoGAP in complex with RhoA. The arrow indicates the catalytic arginine present in the protein RhoGAP but absent in Dd5P4 and OCRL. C) Phylogeny of the OCRL family. Proteins that harbor both an inositol 5-phosphatase catalytic domain and a RhoGAP domain were identified from protein databases. The tree was built using CLUSTALW sequence alignment and PHYLIP (for the alignment we used the entire sequences from the beginning of the 5-phosphatase domain till the last amino acid, see Materials and Methods section Inactivation of dd5p1, dd5p2, dd5p3 or PLIP does not affect growth or development. In contrast, inactivation of dd5p4 reduces axenic growth and inhibits growth on K. aerogens, suggesting a function for Dd5P4 in endocytosis (21) .
In this report, we investigated the role of Dd5P4 during phagocytosis and showed that Dd5P4 is essential for this process. Mutational analysis shows that the inositol 5-phosphatase catalytic domain of Dd5P4 is essential for complementation of the dd5p4-null cells. Transfection of dd5p4-null cells with a truncated Dd5P4 lacking the C-terminal RhoGAP domain does not restore endocytic defects, suggesting that the C-terminal RhoGAP domain is essential as well (21) . We expressed the human homolog OCRL in D. discoideum dd5p4-null cells and showed that expression of OCRL largely restores phagocytosis, growth and developmental defects of dd5p4-null cells.
The requirement for a functional inositol 5-phosphatase catalytic domain suggests that Dd5P4 regulates endocytosis by conversion of phosphoinositides. Recent data (23) have shown that PI(3,4,5)P 3 is formed in the early phagocytic cup upon contact of the particle, whereas PI(3,4)P 2 is formed later, shortly before and during cup closure. Based on our results in dd5p4-null cells with the PI(3,4)P 2 / PI(3,4,5)P 3 reporter PH domain of cytosolic regulator of adenyl cyclase coupled to green fluorescent protein (PHcrac-GFP), we suggest that Dd5P4 mediates the conversion of PI(3,4,5)P 3 to PI(3,4)P 2 at the phagocytic cup, which is necessary for completion of the phagocytic process.
Results
Phylogeny of Dd5P4 and other OCRL-related proteins Both D. discoideum Dd5P4 and human OCRL consist of an N-terminal 5-phosphatase domain and a C-terminal Rho-GAP domain. We searched for the presence of the combination of these two domains in other proteins; databases were searched with BLAST, while domains were analyzed with SMART (see Materials and Methods section). The combination of an inositol 5-phosphatase domain and a Rho-GAP domain is not observed in prokaryotes and only in a limited number of eukaryote species (Figure 1 The position of the D. discoideum protein Dd5P4 relative to the proteins of other species is rather unexpected. It has been well established using phylogeny of many proteins that D. discoideum species evolved after plants, but before the fungi, and certainly far before Caenorhabditis elegans and Drosophila melanogaster. Nevertheless, the D. discoideum OCRL-like protein groups closer to vertebrate OCRL than the proteins from C. elegans, D. melanogaster and fungi. This close relationship is because of the good homology between human and D. discoideum protein over the entire sequence, especially the less-conserved Rho-GAP domain. Therefore, D. discoideum protein Dd5P4 may represent a good candidate to study the function of human OCRL.
Inactivation of Dd5P4 inhibits macropinocytosis and phagocytosis
The commonly used D. discoideum strain AX3 grows both axenically and on bacterial lawns by means of macropinocytosis and phagocytosis, respectively. Inactivation of the gene coding for inositol 5-phosphatase Dd5P4 reduces growth rates in axenic medium and on bacterial lawns to 32 AE 3% and 22 AE 8%, respectively (21, Table 1 ). The doubling time of wild-type cells with control plasmid is 15.7 AE 1.2 h, and increased drastically to 48.1 AE 3.6 h in dd5p4-null cells. When plated in association with K. aerogens as food source, wild-type AX3 cells form visible plaques after 3 days with a plating efficiency of 48 AE 2%. In this assay, only 10.3 AE 0.6% of dd5p4-null cells form plaques. In addition, the plaques of dd5p4-null cells increased in size at approximately 1/5th the rate of wild-type AX3 cells (Table 1) . To directly measure phagocytosis, we labeled heat-killed yeast cells with TRITC (Tetramethyl Rhodamine Iso-Thiocyanate) and measured uptake of these yeast particles by D. discoideum. Wild-type AX3 ingested about 1.5 yeast particles per hour per cell. Inactivation of Dd5P4 almost completely inhibited phagocytosis to about 4% of wild-type AX3 cells (Figure 2A ; see also Figure 6B and Table 1 ).
Proteins are easily expressed in D. discoideum by placing the gene under the D. discoideum actin 15 promotor, transfecting the cells and selecting for transfected cells with G418. The actin 15 promotor ensures expression in the vegetative state as well as during development.
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Expression of Dd5P4-GFP, a protein in which GFP is C-terminally fused to Dd5P4, in dd5p4-null cells restored the defects in phagocytosis of yeast cells and growth on bacteria as well as growth in axenic medium ( Figure 2A , Table 1 ). In fact, the rate of yeast phagocytosis (but not growth on bacteria or in axenic medium) by dd5p4 À / Dd5P4-GFP cells exceeded the rate of phagocytosis of wild-type AX3 cells to 141% of wild type. Overexpression of Dd5P4-GFP in wild-type cells also increased phagocytosis of yeast cells to 133% of wild type ( Figure 2A , Table 1 ).
Expression of Dd5P4-GFP allows for the study of the localization of Dd5P4. In both vegetative and starved cells, Dd5P4-GFP was localized in the cytosol. We could not observe any localization to internal structures or the plasma membrane. Although the cells formed macropinocytic cups, no localization to the cups or endosomes was observed. Also no membrane localization of Dd5P4-GFP was observed in cells during phagocytosis of yeast particles ( Figure 3 ). catalytic domain of SPsynaptojanin (Schizosaccharomyces pombe Synaptojanin), the aspartate present in the first motif was implicated to act as the catalytic base in the dephosphorylation reaction (24) . This is supported by the fact that replacement of this aspartate by an alanine in the human platelet 75-kDa inositol polyphosphate 5-phosphatase II renders a 5-phosphatase inactive version of the protein (25) . We mutated the corresponding aspartate in Dd5P4-GFP, Asp319, to an alanine and expressed the protein (Dd5P4 D319A -GFP) in a dd5p4-null background. Confocal fluoresence microscopy reveals that Dd5P4 D319A -GFP shows the same cytosolic localization as Dd5P4-GFP, both in a wild-type and in a dd5p4-null background (see Figure S1 ), implicating that the mutated protein was expressed at approximately equal levels as the wildtype protein. The growth rate in axenic medium ( Figure 2B ) or on bacterial lawn (Table 1) was not significantly restored in dd5p4 À /Dd5P4 D319A -GFP cells compared to dd5p4 À cells ( Figure 2B , Table 1 ). Uptake of yeast particles by dd5p4
D319A -GFP cells was below detection levels, which is significantly lower than the uptake by dd5p4 À cells ( Figure 2A , Table 1 ). Overexpression of this catalytic inactive 5-phosphatase in wild-type cells (AX3/Dd5P4 D319A -GFP) lead to a statistically significant reduction of axenic growth by 21%, growth on bacteria by 11% and phagocytosis of yeast cells by 10% (Table 1) . This inhibition could be due to competition of endogenously expressed wildtype Dd5P4 with the exogenously expressed catalytic inactive Dd5P4 D319A -GFP.
Dd5P4 contains a 5-phosphatase and a RhoGAP domain. We expressed a deletion mutant containing the active catalytic domain (21), but not the RhoGAP domain. These dd5p4
DRhoGAP cells exhibited similar growth rates as dd5p4 À cells, both in axenic medium and on bacteria, suggesting that an active catalytic domain is not sufficient to complement the dd5p4 À cells. These studies implicate the necessity of both the inositol 5-phosphatase catalytic domain and the RhoGAP domain to restore growth defects.
We also expressed Dd5P4 without GFP tag in dd5p4-null cells because the C-terminal GFP tag may interfere with the function of the essential RhoGAP domain. We observed that Dd5P4 complemented dd5p4 À cells slightly better than Dd5P4-GFP. The 10-20% faster growth in axenic medium and on bacteria is statistically significant.
The PH domain of CRAC localizes to the phagocytic and pinocytic cup in dd5p4-null cells As phagocytosis is almost completely blocked in dd5p4-null cells, we wondered at which step of particle internalization the process was inhibited. The PI(3,4)P 2 /PI(3,4,5)P 3 reporter protein PHcrac-GFP localizes to the phagocytic cup (23, 26) . We studied PHcrac-GFP localization in wildtype and dd5p4-null cells by confocal microscopy. The use of yeast particles labeled with TRITC allowed the detection of both PHcrac-GFP and the yeast cell. Images are presented in Figure 4 and quantitative data in Figure 5 . In wild-type cells, contact of the cell with a yeast particle frequently triggered the formation of a PHcrac-GFP patch. This patch is restricted to the area of contact and increases in size upon extension of the phagocytic cup [(23,26) , Figure 4A ,B). Subsequently, the particle was engulfed and PHcrac-GFP dissociated from the membrane surrounding the particle within 1 min after internalization. On average, we observed approximately one phagocytic attempt per 10 min, which all resulted in a successful uptake of the yeast particle ( Figure 5A ). In dd5p4-null cells, interaction of the yeast particle with membrane components of the cell triggered the formation of a PHcrac-GFP patch as in wildtype cells ( Figure 4C ). The patch was located at the area in contact with the yeast cell and the intensity of the PHcrac-GFP patch was not drastically changed compared to wildtype cells. In addition, the frequency of interaction of dd5p4-null cells with yeast particles was approximately identical to that of wild-type cells ( Figure 5A ). However, these attempts were rarely successful, and we did not observe dd5p4-null cells in which the membrane extended beyond half of the yeast particle. In general, the membrane extensions of the phagocytic cup were withdrawn, the PHcrac-GFP patch disappeared and the yeast particle was subsequently released. In the rare case that we did observe an internalized yeast particle, some of these yeast particles were still labeled with PHcrac-GFP ( Figure 4D) . As a consequence, after 30 min of incubation with yeast particles, dd5p4-null cells contain only 0.06 AE 0.23 yeast particles/cell, compared to 0.96 AE 0.17 yeast particles/cell in wild-type AX3 cells. We conclude that dd5p4-null cells effectively recognize, bind and respond to yeast particles with enhanced PHcrac-GFP localization in the phagocytic cup, but that the phagocytic process is not completed.
We also used the PI(3,4)P 2 reporter TAPP1-PH-GFP in order to detect PI(3,4)P 2 specifically. As observed by was not yet present at the membrane in the first steps of phagocytosis, but was detected just before cup closure. Unfortunately, we have been unable to transform the dd5p4-null cell line with the TAPP1-PH expression vector to investigate the formation of PI(3,4)P 2 during pinocytosis and phagocytosis. In three independent experiments, we observed small clones of cells resistant to the selection Figure 4 . For phagocytosis (A), we determined the number of events per minute of cells that made contact with a yeast particle and exhibited enhanced localization of PHcrac-GFP at the site of interaction, which is defined as attempts. In successful attempts, the yeast particle is engulfed. For pinocytosis (B), we determined the number of pinocytic cups stained with PHcrac-GFP per cell per minute, and the number of closed pinocytic cups visible as vesicles. PHcrac-GFP patches are not only induced upon binding of yeast particles but are also formed at the membrane at apparently random places. In most cases, a pinocytic cup is formed at these positions and liquid is internalized. Localization of PHcrac-GFP to the endosome is visible up to 1 min after internalization. In the dd5p4-null cells, we observed similar structures as in wild-type cells with PHcrac-GFP patches, pinocytic cups and closed macropinosomes ( Figure 4B,D) . However, the frequency at which these structures appear are much lower in dd5p4-null cells (0.33 pinocytic cup/cell/min) than in wild-type cells (1.33 pinocytic cup/cell/min). For wild-type cells, we observed that approximately half of the pinocytic cups closed, yielding a macropinosome visible in the confocal plane, which was also observed in dd5p4-null cells (Figure 5B) . We conclude that pinocytic cups labeled with PHcrac-GFP were formed at a reduced rates in dd5p4-null cells, but that subsequent cup closure and PHcrac-GFP localization to endosomes were not different from wildtype cells.
Expression of human OCRL largely rescues dd5p4-null cells
Sequence analysis of the inositol 5-phosphatase Dd5P4 has revealed the presence of a C-terminal RhoGAP domain (21) . Human OCRL contains a C-terminal RhoGAP domain similar to Dd5P4 (Figure 1) . Furthermore, both the inositol 5-phosphatase catalytic domain and RhoGAP domain of OCRL have a relatively high similarity with the corresponding domains of Dd5P4 (see above). Because of these similarities, we expressed human OCRL in dd5p4-null cells and analyzed the recovery in growth and phagocytosis. Expression of OCRL does restore axenic growth almost to the rate of wild-type cells, although the final cell density does not reach wild-type levels ( Figure 6A , Table 1 ). When plated in association with K. aerogens as food source for 3 days, wild-type AX3 cells have formed plaques with a size of 2.5 AE 1.1 mm at a plating efficiency of 48 AE 2%. In this assay, the plaques of dd5p4-null cells are only 0.5 AE 0.2 mm in size at a significantly lower plating efficiency of 10.3 AE 0.6%. The dd5p4 À /OCRL cells exhibit a plaque size of 1.5 AE 0.5 mm and plating efficiency of 30 AE 2% that are intermediate between dd5p4
À cells and wild-type cells. We also tested the uptake of yeast cells. Whereas the rate of yeast uptake for dd5p4-null cells is about 4% of wildtype AX3 cells, the rate of phagocytosis of dd5p4-null cells expressing OCRL is increased about fivefold to 23% of wild-type cells ( Figure 6B , Table 1 ). Expression of OCRL D422A with a mutation of the catalytic aspartate does not restore growth on bacteria or in axenic medium, indicating that OCRL, as Dd5P4, must be catalytically active to support growth.
Upon starvation, D. discoideum cells form multicellular aggregates. A single tip is formed at the top of the aggregate, and organizes the development into a multicellular slug and eventually a fruiting body with spores. Starvation of dd5p4-null cells results in the formation of multiple-tipped aggregates and consequently small fruiting bodies (21) . Expression of OCRL in dd5p4-null cells restores this defect; cells form normal aggregates, slugs and fruiting bodies (data not shown). The results reveal that human OCRL can replace Dd5P4: phagocytosis of yeast particles is partly restored, plating efficiency and growth on bacterial lawns is largely restored, whereas growth on axenic medium and multicellular development is nearly completely restored.
Discussion
In mammalian cell lines, endocytosis and vesicle trafficking are regulated by phosphoinositides. In D. discoideum, the commonly used PI(3,4)P 2 /PI(3,4,5)P 3 reporter PHcrac-GFP 
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Traffic 2007; 8: 618-628 is located at the pinocytic and phagocytic cup until about 1 min after internalization, suggesting a function for phosphoinositides in endocytosis of D. discoideum cells as well (23, 26) . Inactivation of two D. discoideum PI3Ks, DdPIK1 and DdPIK2, inhibits pinocytosis and inactivation of the 3-phosphatase PTEN inhibits growth on liquid medium and bacteria, supporting a function for phosphoinositides in pinocytosis and phagocytosis (20, 27, 28) .
Function of inositol 5-phosphatase activity during endocytosis Inactivation of the inositol 5-phosphatase dd5p4 results in growth defects, indicating that Dd5P4 participates in endocytosis by regulating phosphoinositide levels (21) . This is supported by data presented in this report showing that, in contrast to wild-type Dd5P4, the inositol 5-phosphatase inactive protein Dd5P4 D319A -GFP did not complement the growth defects of dd5p4-null cells, and even inhibited growth upon expression in wild-type cells. PI(4,5)P 2 and PI(3,4,5)P 3 are degraded in vitro by the catalytic domain of Dd5P4 (21) . As PI(4,5)P 2 is the substrate for PI(3,4,5)P 3 production, reduced degradation of PI(4,5)P 2 or PI(3,4,5)P 3 in vivo could both lead to an increase of PI(3,4,5)P 3 levels.
Upon binding of a yeast cell, wild-type D. discoideum cells form a phagocytic cup. The sides of the cup extend along the yeast cell and eventually enclose the particle by fusion of the extending membranes. Yeast cells were still detected by the dd5p4-null cells at a normal frequency, and small phagocytic cups with membrane extension around the particles were formed as in wild-type cells. However, we rarely observed in dd5p4-null cells the further formation of cups that extended beyond half of the yeast cell or the subsequent fusion of extending membranes. As for wildtype cells, PHcrac-GFP localized to the membrane of dd5p4-null cells that was in contact with the yeast cell and the intensity of the PHcrac-GFP patch was not visibly altered if compared to wild type. This suggests that the total amount of PI(3,4)P 2 /PI(3,4,5)P 3 was not drastically changed in dd5p4-null cells. As lack of inositol 5-phosphatase activity hampers phagocytosis, we suggest that the conversion of PI(3,4,5)P 3 to PI(3,4)P 2 is necessary for extension and closure of the phagocytic cup. Dormann et al. (23) reported on the identity of the phosphoinositides that are formed during pinocytosis and phagocytosis using PH-GFP fusions that are specific for PI(3,4,5)P 3 (GRP1-PH-GFP) or for PI(3,4)P 2 (TAPP1-PH-GFP); PHcrac-GFP detects both PI(3,4,5)P 3 and PI(3,4)P 2 . It was shown that during phagocytosis, PI(3,4,5)P 3 is formed upon attachment of the particle to the cell, while PI(3,4)P 2 becomes detectable significantly later in the process, just before and during cup closure. Transformation of dd5p4-null cells with the TAPP1-PH expression vector yielded cells that died when the clones contained between 10 and 20 cells. Wild-type cells could be transformed with the TAPP1-PH vector, and we confirmed the observations of Dormann et al. (23) . Although many technical explanations are possible for these negative results, we suspect that expression of the PH domain of TAPP1 in dd5p4-null cell is lethal; dd5p4-null cells grow very slowly because of the reduced conversion of PI(3,4,5)P 3 to PI(3,4)P 2 at the closure of the endocyctic cup, and binding of the residual PI(3,4)P 2 by the PH domain of TAPP1 may block endocytosis completely. The study by Dormann et al. (23) and our previous and present experiments strongly suggest that the Dictyostelium OCRL-like protein Dd5P4 is responsible for the conversion of PI(3,4,5)P 3 to PI(3,4)P 2 at the closure of the phagocyctic cup. In this way, Dd5P4 and PI(3,4)P 2 may act as a conditional timer for completion of phagocytosis. In the absence of functional Dd5P4, either because of inactivation of the inositol 5-phosphatase activity or deletion of the RhoGAP domain, phagocytosis stalls halfway and the particle is released.
Implications of the restored endocytic defects by OCRL In this report, we show that human OCRL can partly complement dd5p4-null cells for the lack of Dd5P4. Phagocytosis of yeast cells, that is strongly inhibited in dd5p4-null cells, is restored partly by OCRL from 4 to 22%, whereas the milder growth defects of dd5p4-null cells are restored from 21 to 62% (growth on bacteria) and from 32 to 84% (growth in axenic medium). Mutation of the catalytic aspartate of Dd5P4 renders the protein inactive in complementing dd5p4-null cells. The corresponding catalytic mutation in OCRL does also not complement dd5p4-null cells, suggesting that OCRL exhibits 5-phosphatase activity in D. discoideum. Several mutations in the OCRL gene of patients with Lowe syndrome have been identified leading to reduced 5-phosphatase activity (13) . Dd5P4 contains a C-terminal RhoGAP domain in addition to the inositol 5-phosphatase catalytic domain. This domain is not present in either one of the remaining inositol 5-phosphatases in dd5p4-null cells, the SHIP-like Dd5P1, the unique Dd5P2 and the synaptojanin-like Dd5P3. Transfection of dd5p4-null cells with an extrachromosomal plasmid only containing the catalytic domain of Dd5P4 does not restore any of the observed defects in dd5p4-null cells, including poor growth on bacteria. These observations strongly implicate an essential function for the RhoGAP domain, next to the 5-phosphatase domain, and also suggest the presence of a small G protein in D. discoideum cells that can bind both the RhoGAP domain of Dd5P4 and human OCRL. the RhoGAP domain of Dd5P4 has relatively high similarity with the RhoGAP domain of OCRL. In fact, the RhoGAP domain of Dd5P4 is more closely related to the RhoGAP domain of the human inositol 5-phosphatases OCRL than to other D. discoideum RhoGAP domains present in the data bank. Saccharomyces cerevisiae do not possess OCRL-like proteins with a RhoGAP domain, but three synaptojanin-like inositol 5-phosphatases and one inositol 5-phosphatase not containing another identified domain. Human OCRL-like 5-phosphatase II restores the phenotypic defects of null mutants of these inositol 5-phosphatases (29) , suggesting that the 5-phosphatase activity of OCRL is sufficient for complementation in yeast. However, the necessity of a RhoGAP domain for Dd5P4 function in D. discoideum makes Dd5P4 a good candidate to serve as a model for human OCRL.
Recently, it has been reported that the RhoGAP domain of human OCRL binds to the small G protein Rac1 (30, 31) . For D. discoideum, human Rac1 is closely related to the Dictyostelium Rac1A-C family (unpublished data). Interestingly, it has been demonstrated that the Rac1 family of small G proteins is involved in endocytosis in D. discoideum (32) . Human OCRL is localized to the TGN, but does not contain a membrane-targeting domain (8, 12) . As small G proteins are prenylated and thereby targeted to the membrane, binding of OCRL to Rac1 could mediate the localization of OCRL. Extrapolation of these data to D. discoideum would implicate a role for the RhoGAP domain in membrane localization and explain the requirement for a RhoGAP domain. However, as we could not observe membrane localization of Dd5P4 under the conditions tested, either the interaction with the small G protein is too transient, or the amounts of interacting proteins is too low or the RhoGAP domain does not function as a membrane-targeting domain in D. discoideum.
Expression of human OCRL in dd5p4-null cells restores the endocytic defects, but not to wild-type levels. This could be as a result of poor expression of human OCRL in D. discoideum, to less efficient binding of OCRL to the D. discoideum small G protein and/or to lower GTPase activating protein activity of OCRL compared to Dd5P4. The crystal structure of the human RhoGAP, which is homologous to the RhoGAP domain of Dd5P4 and OCRL, has been solved in complex with the small GTP-binding protein RhoA (33) . This revealed a catalytic role for an arginine, Arg85 p50RhoGAP , located at the loop between helix A and A1. This loop, together with helix B and F, form most of the interactions between RhoGAP and RhoA. Many of the amino acids that interact with the small G protein, including the catalytic arginine, are not conserved in both Dd5P4 and OCRL (Figure 1 ). Furthermore, a number of these amino acids in Dd5P4 are also not similar to the corresponding amino acids in OCRL. This supports the idea that less efficient binding of the RhoGAP domain of OCRL to the D. discoideum small G protein may cause the partial rescue of phagocytosis. Phylogenetic analysis was performed with PHYLIP, using the alignment of the complete proteins, except the very variable section before the 5-phosphatase domain (thus the complete 5-phosphatase domain, RhoGAP domain and domain between 5-phosphatase and RhoGAP).
Materials and Methods

Phylogeny of OCRL-related proteins
Strains and growth conditions
The D. discoideum strains AX3 (wild type), dd5p4-null and derivatives were grown in HG5 medium and supplemented with 10 mg/mL G418 when necessary. When grown in shaking culture, the cell density was kept between 5 Â 10 5 and 6 Â 10 6 cells/mL. To determine growth rate, doubling times were determined in the exponential phase of the growth curve. Growth and development on bacterial lawns was studied using K. aerogens grown on 3Â LP plates (8.3 mM lactose, 2 mM KH 2 PO 4 , 2 mM Na 2 HPO 4 , 15 g/L agar). Unless stated otherwise, D. discoideum cells were grown and assayed at 228C.
Expression of proteins in D. discoideum
To express proteins in D. discoideum, the desired genes were cloned behind the actin 15 promotor of the extrachromosomal plasmid MB74 or DM6. These plasmids contain a neomycin cassette, which allows selection with G418 for cells containing the plasmid. MB74 is a derivative of MB12neo, in which the terminator in the neomycin cassette has been replaced by one actin 8 terminator. DM6 is a derivative of MB74 also containing the gene coding for enhanced GFP. Previously (21), we described the cloning of full-length Dd5P4 and Dd5P4 DRhoGAP (with the name cat5P4). GFP fusion proteins of Dd5P4 were constructed by polymerase chain reaction (PCR) using a reverse primer lacking the stop codon and in frame fusion with the ''GFP open reading frame'' in DM6. To obtain a catalytic inactive mutant, the aspartate at position 319 was mutated into an alanine by site-directed mutagenesis, simultaneously introducing a SacI restriction site by silent mutagenesis of Gly318 and Leu320.
Using PCR, the human OCRL was amplified from pTarget-OCRL and cloned into MB74, yielding plasmid pOCRL. Based on heterologous expression studies (34), we optimized the first 13 codons, using the forward primer OCRL-s1 (AATTAGGATCC ATG GAG CCA CCA CTC CCA GTC GGA GCC CAA CCA CTT GCC), to obtain proper expression of human OCRL in D. discoideum. To obtain a catalytic inactive mutant of OCRL, the aspartate at position 422 was mutated into an alanine by site-directed mutagenesis with plasmid pOCRL as target, simultaneously introducing a SacI restriction 
Phagocytosis assay
Heat-killed yeast cells were fluorescently labeled with TRITC (1 mg/10 10 yeast particles) and resuspended in phosphate buffer (PB) (10 mM Na 2 HPO 4 /KH 2 PO 4 , pH 6.5; 10 9 yeast particles/mL PB) (35) . Dictyostelium discoideum cells were grown in shaking culture, collected and washed once with PB. Cells were resuspended (2 Â 10 7 cells/mL PB) and transferred to glass tubes. Samples (112 mL) were taken after indicated times of incubation at 150 Â g with labeled yeast particles (final concentration of 1.1 Â 10 8 yeast particles/mL). Phagocytosis was stopped by addition of ice-cold PB (1 mL) and samples were kept on ice. After addition of 100 mL trypan blue (2 mg/mL in 20 mM citrate, 150 mM NaCl, pH 4.5) and incubation for 5 min at 200 Â g, cells were spun down (3 min at 500 Â g), resuspended in 1 mL PB and fluorescence was measured (excitation: 544 nm, emission: 574 nm).
Confocal images
To obtain confocal images of cells ingesting yeast, D. discoideum cells were washed with PB and TRITC-labeled yeast particles were added. To obtain confocal images of cells expressing PHcrac-GFP or TAPP1-PH-GFP, cells were transfected with plasmid WF38 (kind gift of P. N. Devreotes) or plasmid TAPP1-PH-GFP (kind gift of C. Weijer), respectively.
Images were obtained using a Zeiss LSM510 confocal fluorescence microscope (Carl Zeiss Jena, Germany) with a Plan-Apochromat Â 63 magnification 1.40 aperture oil immersion objective. Using an argon laser, fluorescence of PHcrac-GFP and TRITC-yeast were determined at wavelengths 488 nm and 543 nm in combination with a 500-530 nm and 565-615 nm filter, respectively.
